Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The fight to manufacture COVID vaccines in lower-income countries

Drug companies and wealthy countries are facing increased pressure to partner with firms in the global south but are reluctant to relinquish control.
  1. Amy Maxmen
    View author publications

    You can also search for this author in PubMed  Google Scholar

Vaccines against COVID-19 are not reaching many people in the global south, despite donations from wealthy nations. Less than 1% of people in low-income countries are fully vaccinated, and just 10% are in lower-middle-income countries, compared with more than half in high-income countries.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 597, 455-457 (2021)

doi: https://doi.org/10.1038/d41586-021-02383-z

Updates & Corrections

  • Correction 16 September 2021: An earlier version of this article misquoted Thomas Cueni as referring to a list of 60 to 70 manufacturers in developing countries. In fact, he was referring to a checklist of 60 to 70 quality control criteria for manufacturers in developing countries, and he had noted that quality control is complex everywhere in the world. The story also incorrectly stated that the Serum Institute is contributing vaccines to COVAX. Although COVAX is expecting doses, an anonymous source with the Indian government told the Hindustan Times that the country’s vaccine export ban stands.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links